rly-4008
relay therapeutics
['rly-4008', 'congrat']
congrats to all our #ditep phase 1 department members from who presented exciting works at #esmo22 in targeted therapies (rly-4008, fgfr2i), new immunotherapies and access to innovative care 
Med onc among other activities. Deputy head @gustaveroussy phase 1 department (#DITEP)
 & GU oncology  @UnivParisSaclay 'scio me nihil scire'